Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

C Rivas; A Djeraba; E Musset; N. van Rooijen; B Baaten; P Quere

doi:10.1080/030794502100007163

Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

C Rivas
, A Djeraba
, E Musset
, N. van Rooijen
, B Baaten
, P Quere

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	139-149
Journal	Avian pathology
Volume	32
Issue number	2
DOIs	https://doi.org/10.1080/030794502100007163
Publication status	Published - 2003

Access to Document

10.1080/030794502100007163

Cite this

@article{52178b90bb1142368fde14575b463744,

title = "Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.",

author = "C Rivas and A Djeraba and E Musset and \{van Rooijen\}, N. and B Baaten and P Quere",

year = "2003",

doi = "10.1080/030794502100007163",

language = "English",

volume = "32",

pages = "139--149",

journal = "Avian pathology",

issn = "0307-9457",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Intravenous treatment with liposome-encapsulated dichloromethylene bisphosphonate (Cl2MBP) suppresses nitric oxide production and reduces genetic resistance to Marek's disease.

AU - Rivas, C

AU - Djeraba, A

AU - Musset, E

AU - van Rooijen, N.

AU - Baaten, B

AU - Quere, P

PY - 2003

Y1 - 2003

U2 - 10.1080/030794502100007163

DO - 10.1080/030794502100007163

M3 - Article

SN - 0307-9457

VL - 32

SP - 139

EP - 149

JO - Avian pathology

JF - Avian pathology

IS - 2

ER -